DEXTER, Mich., Nov. 4, 2015 /PRNewswire/ -- MC3 Cardiopulmonary today announced it has completed the acquisition and transfer of all assets associated with Terumo Cardiovascular's previously marketed Surgical Cannula line, including leading brand names like Sarns™ Soft-Flow® Arterial Cannula.
Founded in 1991, as a spinout of the University of Michigan, MC3 is well known within the medical community as a pioneer in heart/lung extracorporeal life support research. The acquisition marks a major milestone in the Company's goal to transform into a global cardiopulmonary medical device manufacturer.
"This is a significant milestone for us, and we are excited to return the legacy of Soft-Flow® Arterial Cannula to the users and patients it will serve," said Scott Merz, CEO of MC3 Cardiopulmonary. "In order to support our goals as a global medical device company we have built a world-class facility just outside of Ann Arbor in Dexter, Michigan. The location provides close proximity to the University of Michigan, Detroit International Airport and skilled knowhow within our sector."
The Terumo Surgical Cannula was once one of the largest cardiac surgery cannula lines in the world, offering more than 200 product SKUs. The flagship product, the Soft-Flow® Arterial Cannula was the world's first dispersion tip aortic cannula and remains a favorite among clinical users worldwide.
MC3 Cardiopulmonary is a fast growing medical device company located just outside Ann Arbor in Dexter, Michigan. Its mission is to serve the global community by creating life restoring medical devices that address acute and chronic cardiopulmonary clinical needs.
SOURCE MC3 Cardiopulmonary